Small stocks were mixed Wednesday and largely kept pace with the confused broader market, staying flat to negative for much of the day before climbing into positive territory.

Seattle-based biotech Dendreon ( DNDN) was the day's biggest loser overall, and one of the most furiously traded, after the Food and Drug Administration asked for additional clinical data on its prostate-cancer vaccine Provenge before granting approval. Shares plummeted 62% to $6.78.

The Russell 2000, of which Dendreon is a component, was nevertheless higher by 0.4% at 834.41. The S&P SmallCap 600 rose 0.5% to 433.32.

Another small biotech, Curis ( CRIS), got a black eye after Proctor & Gamble ( PG) decided to end its collaboration with the Cambridge, Mass., company, citing an unacceptable safety profile for the hair-growth compounds thus far developed under the agreement. Curis shares plunged 20.5% to $1.47; P&G lately added 0.7% to $62.19.

Oil-and-gas driller Toreador Resources ( TRGL) lost 15.1% to $13.13 after swinging to a steep first-quarter loss, largely blamed on a dry exploration well, against Wall Street's upside expectations from Thomson Financial. The Dallas-based company also filed for a $49.2 million shelf offering after the close Tuesday.

Also reporting lower-than-expected first-quarter bottom lines were Illinois-based TreeHouse Foods ( THS), recently sliding 9% to $29.07, and Hawaii's Hoku Scientific ( HOKU), a clean-energy-technologies developer, giving up 12.2% to $4.43.

Still, a number of small names ratcheted up on impressive earnings. California-based Trio-Tech International ( TRT), purveyor of semiconductor-testing and burn-in services, posted fiscal third-quarter earnings of $1.1 million, or 33 cents a share, compared with a nickel share last year. Revenue more than doubled to $13.6 million. Shares rocketed 28.2%, or $4.59, to $20.85.

BluePhoenix Solutions ( BPHX), an Israel-based business-software firm, jumped 14.3% to $9.70 on mounting non-GAAP profits of 13 cents a share, which skids past the only analyst's estimate for 7 cents. The company separately announced that chief financial officer Iris Yahal will resign from that position, to be replaced by Varda Sagiv.

Elsewhere, Wisconsin-based medical-equipment maker TomoTherapy ( TTPY) surged 22.7% after its initial public offering, which priced some 11.7 million shares at $19 apiece. The offering includes an underwriters' option for another 1.8 million shares to cover any overallotments.

Among others riding high on first-quarter results, St. Louis-based Stereotaxis ( STXS) pared its per-share loss to 31 cents from 47 cents last year and bested the Street's sales targets. Shares leapt 10.9% to $11.61.

Virginia-based coal miner James River Coal's ( JRCC) loss was far narrower than two analysts had forecast, sending shares higher by 10.9% to $10.76, and San Francisco's FiberTower ( FTWR), which sells services to wireless carriers, also reported a smaller-than-expected loss. Shares climbed 12% to $5.15.

More from Investing

Bitcoin Today: Prices Plummet Below $8,000 in Market Downturn

Bitcoin Today: Prices Plummet Below $8,000 in Market Downturn

Why HP Enterprise's Stock Plunged After It Beat Earnings

Why HP Enterprise's Stock Plunged After It Beat Earnings

Has Wall Street Completely Lost Its Mind on General Electric?

Has Wall Street Completely Lost Its Mind on General Electric?

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Did Trump Just Torpedo the Stock Market Again?

Did Trump Just Torpedo the Stock Market Again?